Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1984 Jul;39(7):510–516. doi: 10.1136/thx.39.7.510

Inhibitory capacity of alpha 1 antitrypsin in lung secretions: variability and the effect of drugs.

H M Morrison, S C Afford, R A Stockley
PMCID: PMC459851  PMID: 6611602

Abstract

The inhibitory function of alpha 1 antitrypsin (alpha 1AT) has been studied in the lung secretions of 31 patients with chronic obstructive bronchitis. The inhibitory capacity for a single sample showed a wide range (median 0.13 micrograms porcine pancreatic elastase (PPE) inhibited per microgram alpha 1 antitrypsin; range 0-0.55 micrograms), and all but five of 86 samples studied were capable of inhibiting some porcine pancreatic elastase. No sample showed free elastase activity, however. The inhibitory capacity, studied in six patients over five consecutive days, varied daily within the same individual (coefficient of variation 9.0-108.9%). Corticosteroid treatment (40 mg prednisone daily) increased the inhibitory capacity of sputum alpha 1 antitrypsin in 10 patients (2p less than 0.05) from a median value of 0.13 micrograms PPE inhibited per microgram alpha 1AT (range 0.06-0.36) before treatment to 0.22 micrograms PPE inhibited per microgram alpha 1AT (range 0.09-0.65) after treatment. The inhibitory capacity of sputum was higher than in the corresponding bronchoalveolar lavage sample from the same patient (2p less than 0.05; n = 10). The median value for sputum was 0.22 micrograms PPE inhibited per microgram alpha 1AT (range 0-0.55) and the value for lavage fluid was 0.07 micrograms PPE inhibited per microgram alpha 1AT (range 0-0.27).

Full text

PDF
510

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banda M. J., Clark E. J., Werb Z. Limited proteolysis by macrophage elastase inactivates human alpha 1-proteinase inhibitor. J Exp Med. 1980 Dec 1;152(6):1563–1570. doi: 10.1084/jem.152.6.1563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baumstark J. S., Babin D. R., Lee C. T., Allen R. C. Comparative studies on native and elastase-inactivated alpha 1-protease inhibitor (alpha 1-antitrypsin). Biochim Biophys Acta. 1980 Mar 20;628(3):293–302. doi: 10.1016/0304-4165(80)90378-5. [DOI] [PubMed] [Google Scholar]
  3. Blue M. L., Janoff A. Possible mechanisms of emphysema in cigarette smokers. Release of elastase from human polymorphonuclear leukocytes by cigarette smoke condensate in vitro. Am Rev Respir Dis. 1978 Feb;117(2):317–325. doi: 10.1164/arrd.1978.117.2.317. [DOI] [PubMed] [Google Scholar]
  4. Boudier C., Pelletier A., Pauli G., Bieth J. G. The functional activity of alpha 1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers. Clin Chim Acta. 1983 Aug 31;132(3):309–315. doi: 10.1016/0009-8981(83)90009-8. [DOI] [PubMed] [Google Scholar]
  5. Carp H., Janoff A. Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis. 1978 Sep;118(3):617–621. doi: 10.1164/arrd.1978.118.3.617. [DOI] [PubMed] [Google Scholar]
  6. Carp H., Miller F., Hoidal J. R., Janoff A. Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci U S A. 1982 Mar;79(6):2041–2045. doi: 10.1073/pnas.79.6.2041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Claman H. N. How corticosteroids work. J Allergy Clin Immunol. 1975 Mar;55(3):145–151. doi: 10.1016/0091-6749(75)90010-x. [DOI] [PubMed] [Google Scholar]
  8. Eriksson S. Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl. 1965;432:1–85. [PubMed] [Google Scholar]
  9. GROSS P., PFITZER E. A., TOLKER E., BABYAK M. A., KASCHAK M. EXPERIMENTAL EMPHYSEMA: ITS PRODUCTION WITH PAPAIN IN NORMAL AND SILICOTIC RATS. Arch Environ Health. 1965 Jul;11:50–58. doi: 10.1080/00039896.1965.10664169. [DOI] [PubMed] [Google Scholar]
  10. Gadek J. E., Fells G. A., Zimmerman R. L., Rennard S. I., Crystal R. G. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest. 1981 Oct;68(4):889–898. doi: 10.1172/JCI110344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gadek J. E., Fulmer J. D., Gelfand J. A., Frank M. M., Petty T. L., Crystal R. G. Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease. J Clin Invest. 1980 Jul;66(1):82–87. doi: 10.1172/JCI109838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gadek J. E., Hunninghake G. W., Fells G. A., Zimmerman R. L., Keogh B. A., Crystal R. G. Evaluation of the protease-antiprotease theory of human destructive lung disease. Bull Eur Physiopathol Respir. 1980;16 (Suppl):27–40. doi: 10.1016/b978-0-08-027379-2.50005-3. [DOI] [PubMed] [Google Scholar]
  13. Hochstrasser K., Albrecht G. J., Schönberger O. L., Rasche B., Lempart K. An elastase-specific inhibitor from human bronchial mucus. Isolation and characterization. Hoppe Seylers Z Physiol Chem. 1981 Oct;362(10):1369–1375. doi: 10.1515/bchm2.1981.362.2.1369. [DOI] [PubMed] [Google Scholar]
  14. James H. L., Cohen A. B. Mechanism of inhibition of porcine elastase by human alpha-1-antitrypsin. J Clin Invest. 1978 Dec;62(6):1344–1353. doi: 10.1172/JCI109255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Johnson D., Travis J. Inactivation of human alpha 1-proteinase inhibitor by thiol proteinases. Biochem J. 1977 Jun 1;163(3):639–641. doi: 10.1042/bj1630639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Karlinsky J. B., Snider G. L. Animal models of emphysema. Am Rev Respir Dis. 1978 Jun;117(6):1109–1133. doi: 10.1164/arrd.1978.117.6.1109. [DOI] [PubMed] [Google Scholar]
  17. Lee C. T., Fein A. M., Lippmann M., Holtzman H., Kimbel P., Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N Engl J Med. 1981 Jan 22;304(4):192–196. doi: 10.1056/NEJM198101223040402. [DOI] [PubMed] [Google Scholar]
  18. McGillivray D. H., Burnett D., Afford S. C., Stockley R. A. An evaluation of four methods for the measurement of elastase activity. Clin Chim Acta. 1981 Apr 9;111(2-3):289–294. doi: 10.1016/0009-8981(81)90200-x. [DOI] [PubMed] [Google Scholar]
  19. Reilly C. F., Travis J. The degradation of human lung elastin by neutrophil proteinases. Biochim Biophys Acta. 1980 Jan 24;621(1):147–157. doi: 10.1016/0005-2795(80)90070-7. [DOI] [PubMed] [Google Scholar]
  20. Stockley R. A., Afford S. C. The immunological assessment of alpha 1-antitrypsin with reference to its function in bronchial secretions. Clin Sci (Lond) 1983 Oct;65(4):373–381. doi: 10.1042/cs0650373. [DOI] [PubMed] [Google Scholar]
  21. Stockley R. A., Burnett D. Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection. Bull Eur Physiopathol Respir. 1980;16 (Suppl):261–272. doi: 10.1016/b978-0-08-027379-2.50027-2. [DOI] [PubMed] [Google Scholar]
  22. Tegner H., Ohlsson K., Toremalm N. G., von Mecklenburg C. Effect of human leukocyte enzymes on tracheal mucosa and its mucociliary activity. Rhinology. 1979 Sep;17(3):199–206. [PubMed] [Google Scholar]
  23. Twumasi D. Y., Liener I. E., Galdston M., Levytska V. Activation of human leukocyte elastase by human alpha2-macroglobulin. Nature. 1977 May 5;267(5606):61–63. doi: 10.1038/267061a0. [DOI] [PubMed] [Google Scholar]
  24. Wiggins J., Elliott J. A., Stevenson R. D., Stockley R. A. Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease. Thorax. 1982 Sep;37(9):652–656. doi: 10.1136/thx.37.9.652. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES